Shionogi Announces Licensing of Symproic (naldemedine) to BioDelivery Sciences International Inc.
OSAKA, Japan & FLORHAM PARK, N.J.--(BUSINESS WIRE)--Apr 10, 2019--Shionogi Inc. (hereafter "Shionogi") announced today that BioDelivery Sciences International, Inc. (NASDAQ: BDSI),…
